pyrazinamide has been researched along with niacin in 126 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 108 (85.71) | 18.7374 |
1990's | 3 (2.38) | 18.2507 |
2000's | 6 (4.76) | 29.6817 |
2010's | 9 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Scott, JT | 1 |
Aoki, N; Inoue, K; Sanada, H; Wada, O | 1 |
Aronson, PS; Guggino, SE | 1 |
Cynamon, MH; Speirs, RJ; Welch, JT | 1 |
Ishikawa, A; Kondo, T; Shibata, K | 1 |
Heinzmann, K; Kiener, A; Tinschert, A; Tschech, A | 1 |
Abrigo, C; Calvino, R; Gennaro, MC | 1 |
Fukuwatari, T; Shibata, K; Sugimoto, E | 2 |
DELATTRE, M | 1 |
TARSHIS, MS; WEED, WA | 1 |
CORDICE, JW; HILL, LM; WRIGHT, LT | 1 |
DESSAU, FI; MUNROE, WG; YEAGER, RL | 2 |
DEUSCHLE, K; McCUNE, RM; McDERMOTT, W; MUSCHENHEIM, C; ORMOND, L; TOMPSETT, R | 2 |
CALIX, A; CAMPAGNA, M; HAUSER, G | 1 |
HAIMSOHN, JS; HORTON, GE; LARKIN, JC; LITZENBERGER, WL; PHILLIPS, S | 1 |
BURGER, F; DESSAU, FI; YEAGER, RL | 1 |
GARZA TOBA, M; LATAPI, F; MARQUEZ ITURRIBARRIA, F | 1 |
STEENKEN, W; WOLINSKY, E | 1 |
MOYER, RE; SCHWARTZ, WS | 2 |
PIETROWSKI, JJ; ROBINSON, HJ; SIEGEL, H | 1 |
DEUSCHLE, K; McCUNE, R; McDERMOTT, W; MUSCHENHEIM, C; ORMOND, L; TOMPSETT, R | 1 |
McDERMOTT, W; TOMPSETT, R | 1 |
CHANG, SF; POTTER, BP | 1 |
MORSE, WC; PERRY, CR | 1 |
BATTEN, J; DEUSCHLE, K; MCCUNE, RM; MCDERMOTT, W; MUSCHENHEIM, C; ORGANICK, A; TOMPSETT, R | 1 |
HORTON, GE; PHILLIPS, S | 1 |
DEGLI ESPOSTI, A | 1 |
SVOBODA, GR | 1 |
CULLEN, JH; EARLY, LJ; FIORE, JM | 1 |
DE SIMONI, G; SPINA, G; ZORINI, AO | 1 |
CACCIA, PA | 1 |
FERRARI, S; MORELLINI, M | 3 |
MIYAMOTO, Y; SATO, N; TACHIBANA, T; YANAGISAWA, K | 1 |
DUGGELI, O | 1 |
CROFTON, JW; HAY, D; MURDOCH, JM; STEWART, SM | 1 |
GRIVA, L; MARENGO, G; RANDONE, M; SESIA, L | 1 |
ANSELMETTI-DUGHERA, ML; PESCETTI, G | 1 |
BESTA, B; LUCCHESI, M; ZUBIANI, M | 1 |
SPINA, G; STORNIELLO, G | 1 |
BISETTI, A; FANTOLI, U | 1 |
CATTENEO, C; DE SIMONI, G; FANTILI, U | 1 |
DE SIMONI, G | 1 |
BISETTI, A; DE SIMONI, G; FANTOLI, U | 1 |
CATTANEGO, C; DE SIMONI, G | 1 |
BISETTI, A; DE SIMONI, G; DI DOMENICO, G; MARIANI, B | 1 |
GUALA, B; GUERRA, P; SACCO, F; ZUCCHETTI, B | 3 |
ZORINI, AO | 1 |
FURUTA, M | 1 |
ATWELL, RJ; BROWNING, RH; DONNERBERG, RL | 1 |
BLASI, A; CURCI, G; MONALDI, V | 1 |
CORSINI, F; SILANOS, G | 3 |
DE PASQUALE, N; LA ROSA, G; STAITI, A | 1 |
COSTA, G; GARAVENTA, A; MORETTI, E; PAOLI, G; REALE, M | 1 |
DI PORTO, A; RELLINI, G; ROCCHI, V | 1 |
FREERKSEN, E; ROSENFELD, M | 1 |
MAZZINI, C | 1 |
CULLEN, JH; FIORE, JM; LEVINE, M | 1 |
HYDE, L; SHAPIRO, M | 1 |
MONTALBINE, V; SMITH, MM; STEENKEN, W; WOLINSKY, E | 1 |
EISENBERG, GM; FLIPPIN, HF; KAPLAN, A; WEISS, W | 1 |
CORSINI, F; DEGLI ESPOSTI, A | 1 |
CAIONE, C; MONACO, U; MUZI, F | 1 |
AOKI, T; ITO, F; NISHIO, K | 1 |
POGGIO, G; WRUBL, A | 1 |
BERGER, L; GUTMAN, AB; STONE, DJ; WOLF, J; YU, TF | 1 |
GIOVA, C | 1 |
FIORENTINI, M; PICCHIO, E; ROTTINI, E | 2 |
CALLENS, L; CROISSANT, J; DE BRABANDERE, R; GYSELEN, A | 1 |
PECORA, DV | 1 |
ARRIGONI, G; CIVINO, A | 1 |
SCODITTI, G; SISTI, MA | 1 |
CELLERINO, A; EMANUELE, B; PIOVANO, V; SALVETTI, F | 1 |
LA ROSA, F; TIGANO, F | 1 |
CUIZON, R; SPENGOS, TN | 1 |
GRUMBACH, F | 1 |
DE SIMONI, G; SPINA, G; STORNIELLO, G | 3 |
CANIGLIA, M; DI RUGGIERO, A; GIOVA, C; MARINELLI, N | 1 |
DE SIMONI, GE; SPINA, G; ZORINI, AO | 1 |
HIRASHIKI, Y; KUNIGOSHI, U | 1 |
LINATI, A | 1 |
SPARKUHL, K; WEBB, WR | 1 |
BRUCE, LG; CAMPBELL, AE; CUTHBERT, J; RITCHIE, JA | 1 |
ATWELL, RJ; TOGURI, E | 1 |
COSTA, G; MORETTI, E | 1 |
CIRLA, E; GRASSI, F; SALA, G | 1 |
ALLISON, ST | 1 |
HAY, D; MACLEOD, HM; STEWART, SM | 1 |
SANTOPADRE, I | 2 |
POLIMENI, L | 1 |
BROUET, G; MARCHE, J | 1 |
ATAY, N; STOTTMEIER, D | 1 |
SCHARL, R | 1 |
BUGIE, EJ; GREGORY, FJ; IRONSON, EJ; O'NEILL, RC; PFISTER, R; SOLOTOROVSKY, M | 1 |
KISER, JS; LINDH, H; MALONE, L; McKENZIE, D; SCHURR, A; WILLIAMS, JH | 1 |
BURGER, FJ; DESSAU, FI; WILLIAMS, JH; YEAGER, RL | 1 |
BURGER, F; DESSAU, FI; KULISH, M; YEAGER, RL | 1 |
Akashi, I; Hirano, T; Kagami, K; Oka, K | 1 |
Herrera-León, L; Jiménez Pajares, MS; Molina Moreno, T; Pozuelo-Díaz, R; Saiz Vega, P; Valverde Cobacho, A | 1 |
Anzai, N; Nakanishi, T; Ohya, K; Shimada, S; Tamai, I | 1 |
Holdiness, MR | 1 |
Beurey, J; Cuny, JF; Schmutz, JL; Trechot, P; Weber, M | 1 |
4 review(s) available for pyrazinamide and niacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced gout.
Topics: Cyclosporins; Cytotoxins; Diuretics; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethanol; Fructose; Gout; Humans; Niacin; Pyrazinamide; Salicylates; Uric Acid | 1991 |
[COMPLICATIONS OF A METABOLIC AND ENDOCRINE NATURE PRODUCED BY ANTIBACILLARY CHEMOTHERAPY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Avitaminosis; Cycloserine; Endocrinology; Ethionamide; Isoniazid; Kanamycin; Metabolic Diseases; Niacin; Niacinamide; Pyrazinamide; Streptomycin; Sulfones; Thiosemicarbazones; Toxicology; Viomycin; Vitamin B 6 Deficiency | 1964 |
Adverse cutaneous reactions to antituberculosis drugs.
Topics: Acne Vulgaris; Adult; Amikacin; Antitubercular Agents; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Pellagra; Pigmentation Disorders; Prothionamide; Pyrazinamide; Rifampin; Skin Diseases; Streptomycin; Thioacetazone | 1985 |
122 other study(ies) available for pyrazinamide and niacin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of dietary pyrazinamide, tryptophan, or nicotinic acid and gamma-ray irradiation on levels of NAD and NADP in various organs of mice.
Topics: Animals; Eating; Female; Gamma Rays; Mice; Mice, Inbred C3H; NAD; NADP; Niacin; Organ Specificity; Pyrazinamide; Thymus Gland; Tryptophan | 1989 |
Paradoxical effects of pyrazinoate and nicotinate on urate transport in dog renal microvillus membranes.
Topics: Animals; Biological Transport, Active; Dogs; Hydrogen-Ion Concentration; Kidney Cortex; Lactates; Lactic Acid; Membranes; Microvilli; Models, Biological; Niacin; Nigericin; Pyrazinamide; Sodium; Uric Acid; Valinomycin | 1985 |
Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide.
Topics: Amidohydrolases; Antibiotics, Antitubercular; Drug Resistance, Microbial; Esterases; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Niacin; Pyrazinamide; Structure-Activity Relationship | 1995 |
Effects of dietary pyrazinamide on the metabolism of tryptophan to niacin in streptozotocin-diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glycosuria; Male; Niacin; Poly(ADP-ribose) Polymerase Inhibitors; Pyrazinamide; Rats; Rats, Wistar; Tryptophan | 1997 |
Novel regioselective hydroxylations of pyridine carboxylic acids at position C2 and pyrazine carboxylic acids at position C3.
Topics: Biotransformation; Carboxylic Acids; Culture Media; Gram-Negative Aerobic Rods and Cocci; Hydroxylation; Niacin; Nicotinic Acids; Pyrazinamide; Pyridines; Spectrophotometry, Ultraviolet; Time Factors | 2000 |
Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids.
Topics: Aminosalicylic Acid; Animals; Antitubercular Agents; Calibration; Chromatography, High Pressure Liquid; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Niacin; Pyrazinamide; Pyrazines; Quality Control; Rats | 2001 |
Effects of dietary pyrazinamide, an antituberculosis agent, on the metabolism of tryptophan to niacin and of tryptophan to serotonin in rats.
Topics: Animals; Antitubercular Agents; Diet; Eating; Liver; Male; NAD; NADP; Niacin; Pyrazinamide; Quinolinic Acid; Rats; Rats, Wistar; Serotonin; Tryptophan; Weight Gain | 2001 |
Growth-promoting activity of pyrazinoic acid, a putative active compound of antituberculosis drug pyrazinamide, in niacin-deficient rats through the inhibition of ACMSD activity.
Topics: Animals; Antitubercular Agents; Carboxy-Lyases; Diet; Eating; Injections, Intraperitoneal; Kidney; Kynurenic Acid; Liver; Male; NAD; Niacin; Pyrazinamide; Rats; Rats, Wistar; Tryptophan; Weight Gain; Xanthurenates | 2002 |
[Action of pyrazinamide on experimental and clinical tuberculosis].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1952 |
Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three different solid media.
Topics: Communications Media; In Vitro Techniques; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide; Tunica Media; Veins | 1953 |
Use of pyrazinamide (aldinamide) in the treatment of tuberculous lymphadenopathy and draining sinuses; a preliminary report.
Topics: Disease; Humans; Lymph Nodes; Niacin; Nicotinic Acids; Pyrazinamide; Sternum; Tuberculosis; Tuberculosis, Lymph Node | 1953 |
Pyrazinamide (aldinamide*) in the treatment of pulmonary tuberculosis.
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
Pyrazinamide-isoniazid in tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1954 |
Observations on the combined use of pyrazinamide (Aldinamide) and isoniazid in the treatment of pulmonary tuberculosis; a clinical study.
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Observations on pyrazinamide (Aldinamide) in pulmonary tuberculosis.
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Further studies with aldinamide in experimental tuberculosis of the guinea pig.
Topics: Guinea Pigs; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1953 |
[Pyrazinamide in the treatment of cutanoeus tuberculosis: report of a case].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Cutaneous | 1954 |
The antituberculous activity of pyrazinamide in vitro and in the guinea pig.
Topics: Guinea Pigs; In Vitro Techniques; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1954 |
The chemotherapy of pulmonary tuberculosis with pyrazinamide used alone and in combination with streptomycin, para-aminosalicylic acid, or isoniazid.
Topics: Aminosalicylic Acid; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Toxicity of pyrazinamide.
Topics: Niacin; Nicotinic Acids; Pyrazinamide | 1954 |
Pyrazinamide-isoniazid in tuberculosis. I. Results in 58 patients with pulmonary lesions one year after the start of therapy.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1954 |
Activation of pyrazinamide and nicotinamide in acidic environments in vitro.
Topics: Environment; In Vitro Techniques; Mycobacterium tuberculosis; Niacin; Niacinamide; Nicotinic Acids; Pyrazinamide | 1954 |
The influence of pyrazinamide-isoniazid on M. tuberculosis in animals and man.
Topics: Isomerism; Isoniazid; Leadership; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1954 |
Experience with pyrazinamide.
Topics: Aminosalicylic Acid; Niacin; Nicotinic Acids; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
The pyrazinamide susceptibility of isoniazid-resistant mutants of tubercle bacilli.
Topics: Bacillus; Disease Susceptibility; Gram-Positive Bacteria; Isoniazid; Lacticaseibacillus casei; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide | 1955 |
Pyrazinamide-isoniazid in tuberculosis. III. Observations with reduced dosage of pyrazinamide.
Topics: Clinical Protocols; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1955 |
Pyrazinamide-isoniazid: comparison with isoniazid-para-aminosalicylic acid in active pulmonary tuberculosis with the choice of regimens determined by chance.
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Pyrimidines; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[First results in the treatment of tuberculous meningitis with the use of pyrazinamide and the first studies on its action on isoniazid-resistant strains].
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Pyrimidines; Tuberculosis; Tuberculosis, Meningeal | 1956 |
Polarographic determination of pyrazinamide serum and plasma concentration in the presence of isoniazid.
Topics: Blood; Humans; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Polarography; Pyrazinamide; Pyrimidines | 1956 |
The occurrence of hyperuricemia during pyrazinamide-isoniazid therapy.
Topics: Blood; Humans; Hyperuricemia; Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Pyrimidines; Uric Acid | 1956 |
[Possible therapeutic use of new preparations with antituberculous action (pyrazinamide and cycloserine); preliminary note].
Topics: Anti-Bacterial Agents; Cycloserine; Humans; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
Spectrophotometric determination of pyrazinamide blood concentrations and excretion through the kidneys.
Topics: Body Fluids; Niacin; Nicotinic Acids; Pyrazinamide; Spectrophotometry | 1957 |
[Activity of pyrazinamide (pyrazine-2-carboxylic acid amide) in experimental tuberculosis of the cavy].
Topics: Amides; Guinea Pigs; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1956 |
[The effect of pyrazinamide on experimental tuberculosis in mice].
Topics: Animals; Mice; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1956 |
[Clinical experiences with pyrazinamide].
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
Pyrazinamide together with oxytetracycline in patients with tubercle bacilli resistant to streptomycin, PAS and isoniazid.
Topics: Aminosalicylic Acid; Bacillus; Isoniazid; Lacticaseibacillus casei; Niacin; Nicotinic Acids; Oxytetracycline; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Treatment of chronic pulmonary tuberculosis with pyrazinamide].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1956 |
[In vitro and electron microscopical observations on the antimycobacterial activity of pyrazinamide].
Topics: Anti-Bacterial Agents; Electrons; Humans; In Vitro Techniques; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide | 1957 |
[In vitro studies of pyrazinamide action on Mycobacteria tuberculosis showing resistance and sensitivity to specific chemotherapy and antibiotics; comparative studies].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Humans; In Vitro Techniques; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide; Research; Tuberculosis | 1957 |
[Effects of pyrazinamide on experimental tuberculosis in guinea pigs].
Topics: Animals; Cortisone; Guinea Pigs; Humans; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1957 |
[Behavior of the Middlebrook-Dubos reaction and of phagocytosis in pulmonary tuberculosis treated with pyrazinamide].
Topics: Humans; Niacin; Nicotinic Acids; Phagocytosis; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Elimination of urinary 17-ketosteroids in pulmonary tuberculosis treated with pyrazinamide].
Topics: 17-Ketosteroids; Humans; Niacin; Nicotinic Acids; Pyrazinamide; Steroids; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Determination of prothrombin time (Quick test) and plasma fibrinogen in pulmonary tuberculosis treated with pyrazinamide].
Topics: Fibrinogen; Humans; Niacin; Nicotinic Acids; Prothrombin Time; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Blood iodine precipitation and cholesteremia in pulmonary tuberculosis treated with pyrazinamide].
Topics: Cholesterol; Humans; Iodine; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Peripheral blood picture in pulmonary tuberculosis treated with pyrazinamide].
Topics: Humans; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Blood proteins in pulmonary tuberculosis treated with pyrazinamide; electrophoresis and serodiagnosis].
Topics: Blood Proteins; Electrophoresis; Humans; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Effects of pyrazinamide and cycloserine therapy of tuberculosis on clinical and functional liver reactions and on certain biological tests].
Topics: Anti-Bacterial Agents; Cycloserine; Humans; Liver; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1957 |
[Pyrazinamide in the treatment of pulmonary tuberculosis].
Topics: Humans; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Combination of pyrazinamide & isoniazid in experimental tuberculosis in guinea pigs].
Topics: Animals; Guinea Pigs; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1956 |
[Liver function and pyrazinamide therapy of pulmonary tuberculosis].
Topics: Liver; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Two new antituberculotic drugs: pyrazinamide & cycloserine].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1957 |
[Action of pyrazinamide on experimental tuberculosis in mice; comparison of oral and subcutaneous administration].
Topics: Animals; Mice; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1956 |
Pyrazinamide-isoniazid in patients with previous isoniazid therapy.
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
A STATEMENT of pyrazinamide.
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1957 |
[Clinical aspects and experimental data on the use of pyrazinamide in tuberculous infection].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1957 |
[Cerebrospinal fluid concentration of pyrazinamide administered in therapeutic doses].
Topics: Niacin; Nicotinic Acids; Pyrazinamide | 1957 |
[Pyrazinamide in pulmonary and extrapulmonary tuberculosis; clinical aspects].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1957 |
[Treatment of pulmonary tuberculosis with high alternating dosage of pyrazinamide and isoniazid].
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Pyrazinamide in pulmonary tuberculosis; behavior of blood proteins].
Topics: Blood Proteins; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Experimental treatment with pyrazinamide alone].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Therapies, Investigational; Tuberculosis | 1957 |
[Concentration of pyrazinamide in blood after oral administration of therapeutic dose].
Topics: Administration, Oral; Niacin; Nicotinic Acids; Pyrazinamide | 1957 |
[Pyrazinamide-isoniazid mixture in the treatment of chronic pulmonary tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Studies of hyperuricemia produced by pyrazinamide.
Topics: Humans; Hyperuricemia; Niacin; Nicotinic Acids; Pyrazinamide; Uric Acid | 1957 |
Hyperuricemia due to pyrazinamide.
Topics: Humans; Hyperuricemia; Niacin; Nicotinic Acids; Pyrazinamide; Uric Acid | 1957 |
Further observations of pyrazinamide alone and in combination with other drugs in experimental tuberculosis.
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1957 |
The effect of probenecid on pyrazinamide blood levels and pyrazinamide-induced hyperuricemia.
Topics: Humans; Hyperuricemia; Niacin; Nicotinic Acids; Probenecid; Pyrazinamide; Uric Acid | 1957 |
[Use of pyrazinamide in acute tuberculous disseminations; 1 year's experience in the Centro Meningitic di Bologna].
Topics: Child; Humans; Infant; Meningitis; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Meningeal | 1957 |
[Therapy of tuberculous adenopathy in infants; clinical experiences with pyrazinamide].
Topics: Child; Humans; Infant; Lymph Nodes; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Lymph Node | 1957 |
[Pyrazinamide concentration in blood after its rectal administration].
Topics: Administration, Rectal; Niacin; Nicotinic Acids; Pyrazinamide | 1957 |
[Research on the metabolic fate of pyrazinamide; pyrazinoic acid formation by liver homogenates in vitro].
Topics: In Vitro Techniques; Liver; Niacin; Nicotinic Acids; Pyrazinamide; Research | 1957 |
[Pyrazinamide & pyrazinamide with isoniazid in pulmonary tuberculosis; comparison with other chemotherapeuticantibiotic combinations].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Effect of pyrazinamide and pyrazinoic acid on urate clearance and other discrete renal functions.
Topics: Humans; Kidney Function Tests; Niacin; Nicotinic Acids; Pyrazinamide; Uric Acid; Urinary Tract Physiological Phenomena | 1957 |
[The phenomenon of tanned skin in tuberculotics treated with pyrazinamide].
Topics: Niacin; Nicotinic Acids; Pigmentation; Pyrazinamide; Tuberculosis | 1957 |
Pyrazinamide and cycloserine in the treatment of pulmonary tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Pyrazinamide and gastric functional response in pulmonary tuberculosis].
Topics: Humans; Niacin; Nicotinic Acids; Pyrazinamide; Stomach; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Pyrazinamide in therapy of cavitary tuberculosis resistant to usual therapy].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Pyrazinamide and viomycin in the surgical treatment of pulmonary tuberculosis.
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1958 |
[Possibility of the use of pyrazinamide in renal tuberculosis].
Topics: Kidney; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Renal | 1957 |
[Combined pyrazinamide and isoniazid in therapy of pulmonary tuberculosis].
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Liver function tests of pulmonary tuberculosis patients treated with pyrazinamide].
Topics: Liver; Liver Function Tests; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Experience on the use of pyrazinamide in the treatment of pulmonary tuberculosis. I. Clinical results].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Effects of pyrazinamide on phenomena connected with blood coagulation; in vitro studies].
Topics: Blood Coagulation; In Vitro Techniques; Niacin; Nicotinic Acids; Pyrazinamide; Research | 1958 |
Pyrazinamide-induced acute yellow atrophy of the liver: case report and post-mortem findings.
Topics: Humans; Massive Hepatic Necrosis; Niacin; Nicotinic Acids; Pyrazinamide | 1958 |
[Activity of pyrazinamide against experimental tuberculosis].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1958 |
[Behavior of hemagglutinating antibodies and electrophoretic patterns of globulins in animals vaccinated with killed Koch bacilli and simultaneously treated with cycloserine and pyrazinamide].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antibodies; Cycloserine; Globulins; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide; Serum Globulins; Tuberculosis | 1957 |
[Pyrazinamide and gastric functional response in pulmonary tuberculosis].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Stomach; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Radiological records of the results of combined pyrazinamide-streptomycin-isoniazid therapy].
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Radiology; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
Clinical and biological investigations on the new antituberculosis drugs (pyrazinamide and cycloserine).
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Experimental studies on the mode of action of pyrazinamide. I. The relation with isoniazid].
Topics: Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1958 |
[Pyrazinamide-isoniazid combination in treatment of bone tuberculosis].
Topics: Humans; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Osteoarticular | 1958 |
Pulmonary resection for tuberculosis under protection of viomycin, promizole and pyrazinamide.
Topics: Niacin; Nicotinic Acids; Pneumonectomy; Pyrazinamide; Sulfathiazole; Sulfathiazoles; Thiazoles; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1958 |
Treatment of drug-resistant cases of pulmonary tuberculosis with cycloserine and pyrazinamide.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
Cycloserine combined with pyrazinamide in the treatment of pulmonary tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Behavior of hemagglutinating antibodies & electrophoretic globulins in animals vaccinated with killed Koch's bacillus & contemporaneously treated with cycloserine & pyrazinamide].
Topics: Agammaglobulinemia; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacillus; Cycloserine; Globulins; Hemagglutination; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1958 |
[Behavior of the Middlebrook-Dubos reaction & blood protein picture in healthy rabbits treated with pyrazinamide & cycloserine & in rabbits pretreated with the same drugs & successively infected with Mycobacterium tuberculosis bovis].
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Blood Proteins; Cycloserine; Hemagglutination; Hemagglutination Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide; Rabbits; Tuberculosis | 1958 |
[Pyrazinamide in solution, for topical use, in the treatment of tuberculous empyema].
Topics: Empyema, Tuberculous; Humans; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1958 |
[Effect of pyrazinamide on uric acid metabolism].
Topics: Humans; Niacin; Nicotinic Acids; Pyrazinamide; Uric Acid | 1958 |
Pyrazinamide in low dosage in combination with isoniazid or paraaminosalicylic acid in the treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acid; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Newer tuberculostatics: pyrazinamide & cycloserine].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1958 |
PYRAZINAMIDE.
Topics: Isomerism; Niacin; Nicotinic Acids; Pyrazinamide | 1959 |
The use of pyrazinamide plus isoniazid in the treatment of pulmonary tuberculosis.
Topics: Isomerism; Isoniazid; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1959 |
[Tests of liver function during pyrazinamide therapy].
Topics: Child; Humans; Infant; Isoniazid; Liver; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1959 |
[Liver function tests during pyrazinamide therapy].
Topics: Child; Humans; Infant; Liver; Liver Function Tests; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1959 |
[Observations on therapy of pulmonary tuberculosis with viomycin pyrazinamide & cycloserine].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Humans; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1959 |
[COMPARISON OF CULTURE AND BIOCHEMICAL METHODS FOR THE DIFFERENTIATION OF MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM BOVIS WITH SPECIAL REFERENCE TO STRAINS WITH HIGH ISONIAZID RESISTANCE].
Topics: Cell Differentiation; Culture Media; Drug Resistance, Microbial; Isoniazid; Mycobacterium bovis; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Nitrates; Oxidoreductases; Pyrazinamide; Research | 1964 |
[On the tuberculostatic effect of pyrazinamide].
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1959 |
Pyrazinoic acid amide; an agent active against experimental murine tuberculosis.
Topics: Amides; Animals; Humans; Mice; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1952 |
The effect of pyrazinamide (aldinamide) on experimental tuberculosis in mice.
Topics: Animals; Mice; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1952 |
Pyrazinamide (aldinamide) in experimental tuberculosis of the guinea pig.
Topics: Guinea Pigs; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis | 1952 |
Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis.
Topics: Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
A method for the determination of in vitro sensitivity of tubercle bacilli to pyrazinamide (aldinamide).
Topics: Animals; Bacillus; Gram-Positive Bacteria; In Vitro Techniques; Insecta; Lacticaseibacillus casei; Mycobacterium tuberculosis; Niacin; Nicotinic Acids; Pyrazinamide | 1952 |
Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.
Topics: Alanine Transaminase; Alkaloids; Animals; Aspartate Aminotransferases; Caffeine; Chemical and Drug Induced Liver Injury; Chlorogenic Acid; Coffee; Galactosamine; Interleukin-10; Lipopolysaccharides; Liver Diseases; Male; Niacin; Pyrazinamide; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2009 |
[Differentiation of species within the Mycobacterium tuberculosis complex by molecular techniques].
Topics: Animals; Bacterial Proteins; Carboxylic Acids; Cattle; Chaperonin 60; DNA Gyrase; DNA, Bacterial; Humans; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Niacin; Nitrates; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrazinamide; Reference Standards; Sensitivity and Specificity; Species Specificity; Thiophenes; Tuberculosis; Tuberculosis, Bovine | 2009 |
Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.
Topics: Animals; Benzbromarone; Cells, Cultured; Dogs; Fluorescent Antibody Technique; Glucose Transport Proteins, Facilitative; Humans; Kidney; Lactic Acid; Madin Darby Canine Kidney Cells; Niacin; Oocytes; Organic Anion Transporters; Organic Cation Transport Proteins; Pyrazinamide; Uric Acid; Uricosuric Agents; Vasodilator Agents; Xenopus laevis | 2013 |
[Drug-induced pellagroid erythema. A case of pellagroid erythema caused by isoniazide].
Topics: Antineoplastic Agents; Erythema; Ethionamide; Female; Humans; Isoniazid; Middle Aged; Monoamine Oxidase Inhibitors; Niacinamide; Pellagra; Pyrazinamide; Pyridoxine; Skin | 1987 |